Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Nov;6(6):1132-8.
doi: 10.1161/CIRCHEARTFAILURE.113.000163. Epub 2013 Oct 15.

Practice-level variation in use of recommended medications among outpatients with heart failure: Insights from the NCDR PINNACLE program

Pamela N Peterson  1 , Paul S Chan, John A Spertus, Fengming Tang, Philip G Jones, Justin A Ezekowitz, Larry A Allen, Frederick A Masoudi, Thomas M Maddox
Affiliations
Comparative Study

Practice-level variation in use of recommended medications among outpatients with heart failure: Insights from the NCDR PINNACLE program

Pamela N Peterson et al. Circ Heart Fail. 2013 Nov.

Abstract

Background: The objective of this study is to examine practice-level variation in rates of guideline-recommended treatment for outpatients with heart failure and reduced ejection fraction, and to examine the association between treatment variation and practice site, independent of patient factors.

Methods and results: Cardiology practices participating in the National Cardiovascular Disease Registry Practice Innovation and Clinical Excellence registry from July 2008 to December 2010 were evaluated. Practice rates of treatment with angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and β-blockers and an optimal combined treatment measure were determined for patients with heart failure and reduced ejection fraction and no documented contraindications. Multivariable hierarchical regression models were adjusted for demographics, insurance status, and comorbidities. A median rate ratio was calculated for each therapy, which describes the likelihood that the treatment of a patient with given comorbidities would differ at 2 randomly selected practices. We identified 12 556 patients from 45 practices. The unadjusted practice-level prescription rates ranged from 44% to 100% for angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (median, 85%; interquartile range, 75%-89%), from 49% to 100% for β-blockers (median, 92%; interquartile range, 83%-95%), and from 37% to 100% for optimal combined treatment (median, 79%; interquartile range, 66%-85%). The adjusted median rate ratio was 1.11 (95% confidence interval, 1.08-1.18) for angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy, 1.08 (95% confidence interval, 1.05-1.15) for β-blockers therapy, and 1.17 (1.13-1.26) for optimal combined treatment.

Conclusions: Variation in the use of guideline-recommended medications for patients with heart failure and reduced ejection fraction exists in the outpatient setting. Addressing practice-level differences may be an important component of improving quality of care for patients with heart failure and reduced ejection fraction.

Keywords: heart failure; pharmaceutical preparations; registries.

PubMed Disclaimer

Conflict of interest statement

Disclosures

None of the other authors have any conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Variation in rate of prescription of ACEI/ARB across practices.
Figure 2
Figure 2
Variation in rate of prescription of BB across practices.
Figure 3
Figure 3
Variation in composite prescription rate across practices.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC, Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation. 2005;112:1825–1852. - PubMed
    1. Fonarow GC, Yancy CW, Heywood JT for the ADHERE Scientific Advisory Committee SGaI. Adherence to Heart Failure Quality-of-Care Indicators in US Hospitals: Analysis of the ADHERE Registry. Arch Intern Med. 2005;165:1469–1477. - PubMed
    1. Peterson PN, Rumsfeld JS, Liang L, Hernandez AF, Peterson ED, Fonarow GC, Masoudi FA on behalf of the American Heart Association Get With the Guidelines-Heart Failure Program. Treatment and Risk in Heart Failure: Gaps in Evidence or Quality? Circ Cardiovasc Qual Outcomes. 2010;3:309–315. - PubMed
    1. Bonow RO, Ganiats TG, Beam CT, Blake K, Casey DE, Jr, Goodlin SJ, Grady KL, Hundley RF, Jessup M, Lynn TE, Masoudi FA, Nilasena D, Pina IL, Rockswold PD, Sadwin LB, Sikkema JD, Sincak CA, Spertus J, Torcson PJ, Torres E, Williams MV, Wong JB American College of Cardiology Foundation, American Heart Association Task Force on Performance Measures, American Medical Association-Physician Consortium for Performance Improvement. ACCF/AHA/AMA-PCPI 2011 Performance Measures for Adults With Heart Failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. Circulation. 2012;125:2382–2401. - PubMed
    1. Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Inge PJ, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW. Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices. Circulation. 2010;122:585–596. - PubMed

Publication types

Substances